Mike Kagey

Vice President of Translational Medicine at Leap Therapeutics

Role
Vice President of Translational Medicine at Leap Therapeutics
Location
Cambridge, MA, US
LinkedIn followers
500 followers

About Mike Kagey

Translational medicine leader with a proven track record in advancing the biomarker lifecycle through discovery, assay validation, patient selection for clinical trials, and CDx development across multiple oncology indications.

Experience

  1. Vice President of Translational Medicine

    Leap Therapeutics

    Mar 2023 — Present · Cambridge, MA, US

    Leading translational biomarker and companion diagnostic (CDx) efforts across Leap Therapeutics oncology pipeline. Working cross functionally with clinical development, operations and regulatory to design and execute on biomarker strategy- Led CDx efforts for DKN-01 and successfully advanced a novel tumoral RNAscope assay to a Phase 3 ready IVD for gastric/gastroesophageal junction cancer- Oversaw exploratory clinical biomarker generation (genetics, proteomics, RNA-Seq and IHC) across multiple oncology indications to inform on mechanism of action, prognostic and predicative markers and guide future combinations and indications- Through collaborations with external CROs and academic partners, discovered a novel plasma biomarker for DKN-01 treatment of colorectal cancer that is currently being developed as a CDx- Led efforts to develop nonclinical PK and PD assays for an anti-GDF-15 therapeutic antibody - Supported business development activities through presentations to potential partners, answering of diligence questions and conducting scientific diligence of Flame Therapeutics acquisition in January 2023- Oversaw direct reports at Director and Scientist levels

Education

  • Bucknell University

    B.S., Biochemistry and Cell Biology

    1996 — 2000

  • University of Virginia

    Ph.D., Biochemistry and Molecular Genetics

    2000 — 2006

Skills

  • Chromatin Biology
  • Molecular Cloning
  • Protein Expression
  • Biochemistry
  • High Throughput Screening
  • Western Blotting
  • Genomics
  • Transfection
  • Immunofluorescence
  • Transcription
  • Adme
  • Qpcr
  • Epigenetics
  • Fluorescence Microscopy
  • Drug Development
  • Cancer
  • Embryonic Stem Cells
  • Cell Culture
  • Bioinformatics
  • Managing Cros
  • Microarray Analysis
  • Xenografts

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Mike Kagey — Vice President of Translational Medicine at Leap Therapeutics in Cambridge, MA, US | Unifers